Hyelee Kim

Hyelee Kim

Auto-generated profile, based on publicly available information

Hyelee Kim

School of Biomedical Engineering and Interdisciplinary Program in Precision Public Health Korea University Seoul Republic of Korea

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2024 in Lab on a Chip
Verified
Journal Article
Open access
PDF file
HKHyelee Kim
Hyelee Kim
SKSuyeon Kim
Suyeon Kim
HLHyunjung Lim
Hyunjung Lim
ACAram J. Chung
Aram J. Chung
This review outlines Chimeric antigen receptor (CAR)-T cell manufacturing, highlights challenges, and explores successful microfluidic approaches and related technologies to address them.

28 July 2023 in Nano Letters
Verified
Journal Article
Closed access
JHJeongsoo Hur
Jeongsoo Hur
HKHyelee Kim
Hyelee Kim
UKUijin Kim
Uijin Kim
GKGi-Beom Kim
Gi-Beom Kim
JKJinho Kim
Jinho Kim
ACAram J. Chung
Aram J. Chung

7 March 2025 in Advanced Science
Verified
Journal Article
Open access
HKHyelee Kim
Hyelee Kim
MLMujin Lee
Mujin Lee
BHBohwa Han
Bohwa Han
JKJinho Kim
Jinho Kim
DCDuck Cho
Duck Cho
ACAram J. Chung
Aram J. Chung
Chimeric antigen receptor (CAR)‐T cell therapy has revolutionized cancer treatment, yet challenges such as manufacturing complexity, high costs, and safety concerns have spurred the development of alternatives like CAR‐natural killer (NK) cell immunotherapies. CAR‐NK cell therapies provide innate cytotoxicity with antigen‐independent targeting, reducing safety risks while improving therapeutic efficacy. However, efficient genomic engineering and large‐scale production of allogeneic NK cells remain significant obstacles. To address these challenges, a novel microfluidic gene delivery platform is developed, the Y‐hydroporator, designed for allogeneic NK cell immunotherapy. This platform features a Y‐shaped microchannel where NK cells experience rapid hydrodynamic stretching near the stagnation point, creating transient membrane discontinuities that facilitate the uptake of exogenous cargo. The Y‐hydroporator achieves high delivery and transfection efficiency, processing ≈2 × 10 6 cells min −1 while maintaining long‐term cell viability (>89%) and functionality. Using this platform, human primary CAR‐NK cells and NKG2A‐knockout NK cells are successfully generated by delivering anti‐CD19 CAR mRNA and CRISPR/Cas9 ribonucleoproteins, respectively. These engineered NK cells demonstrated enhanced cytotoxicity, underscoring the potential of the Y‐hydroporator as a transformative tool for advancing allogeneic NK cell‐based immunotherapies.

26 February 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
SJSoo Bin Jang
Soo Bin Jang
TJTak-Il Jeon
Tak-Il Jeon
GKGeun-Ho Kang
Geun-Ho Kang
DSDongwhan Seo
Dongwhan Seo
HKHyelee Kim
Hyelee Kim
Ssang-Goo ChoSsang-Goo Cho
Ssang-Goo Cho
Stem cell aging significantly impairs therapeutic efficacy, requiring innovative strategies to restore potency. We present a microfluidic cell-compressing platform for reactivation (μ-CPR) designed to apply controlled hydrodynamic deformation to late-passage stem cells. This mechanical stimulation facilitates functional reactivation without external chemical cues. Within a defined window, μ-CPR effectively reduces oxidative stress, SA-β-Gal activity, and γH2AX foci, while simultaneously restoring proliferation and canonical stemness markers (OCT4, SOX2, and KLF4). Mechanical stimulation via μ-CPR induces coordinated structural remodeling: nuclei become more compact, actin cortex organization is restored, α-actinin redistributes to focal adhesions, and microtubule networks are restructured, suggesting a rebalanced intracellular tension. Transcriptomic and proteomic analyses reveal that this process reprograms extracellular matrix remodeling and DNA repair pathways while attenuating pro-fibrotic and senescence-associated secretory phenotype (SASP)-associated pathways. Crucially, this reactivation occurs without compromising fundamental MSC hallmarks, preserving intrinsic immunophenotypes and multilineage differentiation potential. Functionally, μ-CPR-processed stem cells demonstrate restored in vitro wound closure and enhanced tissue repair in vivo , with efficacy appearing dependent on mechanical dosage. This platform establishes a non-genetic, mechanobiological approach to restoring stem cell function, offering a scalable strategy for functional reactivation and potentially paving the way toward comprehensive cellular rejuvenation.

9 September 2026 in Small
Verified
Journal Article
Closed access
PDF file
SJSoo Bin Jang
Soo Bin Jang
TJTak-il Jeon`
Tak-il Jeon`
GKGeun-Ho Kang
Geun-Ho Kang
DSDonghwan Seo
Donghwan Seo
HKHyelee Kim
Hyelee Kim
Ssang-Goo ChoSsang-Goo Cho
Ssang-Goo Cho